{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418520398858752.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0140-6736(04)17551-x"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S014067360417551X?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S014067360417551X?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"15589308"}},{"identifier":{"@type":"NAID","@value":"30006113053"}}],"dc:title":[{"@value":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis"}],"description":[{"notation":[{"@value":"Neuromyelitis optica is an inflammatory demyelinating disease with generally poor prognosis that selectively targets optic nerves and spinal cord. It is commonly misdiagnosed as multiple sclerosis. Neither disease has a distinguishing biomarker, but optimum treatments differ. The relation of neuromyelitis optica to optic-spinal multiple sclerosis in Asia is uncertain. We assessed the capacity of a putative marker for neuromyelitis optica (NMO-IgG) to distinguish neuromyelitis optica and related disorders from multiple sclerosis.Indirect immunofluorescence with a composite substrate of mouse tissues identified a distinctive NMO-IgG staining pattern, which we characterised further by dual immunostaining. We tested masked serum samples from 102 North American patients with neuromyelitis optica or with syndromes that suggest high risk of the disorder, and 12 Japanese patients with optic-spinal multiple sclerosis. Control patients had multiple sclerosis, other myelopathies, optic neuropathies, and miscellaneous disorders. We also established clinical diagnoses for 14 patients incidentally shown to have NMO-IgG among 85000 tested for suspected paraneoplastic autoimmunity.NMO-IgG outlines CNS microvessels, pia, subpia, and Virchow-Robin space. It partly colocalises with laminin. Sensitivity and specificity were 73% (95% CI 60-86) and 91% (79-100) for neuromyelitis optica and 58% (30-86) and 100% (66-100) for optic-spinal multiple sclerosis. NMO-IgG was detected in half of patients with high-risk syndromes. Of 14 seropositive cases identified incidentally, 12 had neuromyelitis optica or a high-risk syndrome for the disease.NMO-IgG is a specific marker autoantibody of neuromyelitis optica and binds at or near the blood-brain barrier. It distinguishes neuromyelitis optica from multiple sclerosis. Asian optic-spinal multiple sclerosis seems to be the same as neuromyelitis optica."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381418520398858754","@type":"Researcher","foaf:name":[{"@value":"Vanda A Lennon"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520398858759","@type":"Researcher","foaf:name":[{"@value":"Dean M Wingerchuk"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520398858758","@type":"Researcher","foaf:name":[{"@value":"Thomas J Kryzer"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520398858753","@type":"Researcher","foaf:name":[{"@value":"Sean J Pittock"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520398858755","@type":"Researcher","foaf:name":[{"@value":"Claudia F Lucchinetti"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520398858756","@type":"Researcher","foaf:name":[{"@value":"Kazuo Fujihara"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520398858752","@type":"Researcher","foaf:name":[{"@value":"Ichiro Nakashima"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520398858757","@type":"Researcher","foaf:name":[{"@value":"Brian G Weinshenker"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01406736"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/01406736"}],"prism:publicationName":[{"@value":"The Lancet"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2004-12","prism:volume":"364","prism:number":"9451","prism:startingPage":"2106","prism:endingPage":"2112"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S014067360417551X?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S014067360417551X?httpAccept=text/plain"}],"createdAt":"2004-12-11","modifiedAt":"2025-09-25","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Multiple%20Sclerosis","dc:title":"Multiple Sclerosis"},{"@id":"https://cir.nii.ac.jp/all?q=Optic%20Neuritis","dc:title":"Optic Neuritis"},{"@id":"https://cir.nii.ac.jp/all?q=Neuromyelitis%20Optica","dc:title":"Neuromyelitis Optica"},{"@id":"https://cir.nii.ac.jp/all?q=Brain","dc:title":"Brain"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Sensitivity%20and%20Specificity","dc:title":"Sensitivity and Specificity"},{"@id":"https://cir.nii.ac.jp/all?q=Diagnosis,%20Differential","dc:title":"Diagnosis, Differential"},{"@id":"https://cir.nii.ac.jp/all?q=Recurrence","dc:title":"Recurrence"},{"@id":"https://cir.nii.ac.jp/all?q=Immunoglobulin%20G","dc:title":"Immunoglobulin G"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Fluorescent%20Antibody%20Technique,%20Indirect","dc:title":"Fluorescent Antibody Technique, Indirect"},{"@id":"https://cir.nii.ac.jp/all?q=Biomarkers","dc:title":"Biomarkers"},{"@id":"https://cir.nii.ac.jp/all?q=Autoantibodies","dc:title":"Autoantibodies"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050018904748235520","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort study"}]},{"@id":"https://cir.nii.ac.jp/crid/1050022457824907776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Contribution of germline and somatic mutations to risk of neuromyelitis optica spectrum disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1050283688739179904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1050568772229080320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Proteomic approach to profiling immune complex antigens in cerebrospinal fluid samples from patients with central nervous system autoimmune diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1050570022174265088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"視神経脊髄炎と多発性硬化症の免疫病態の相違"},{"@value":"第二回千葉医学会奨励賞 視神経脊髄炎と多発性硬化症の免疫病態の相違"},{"@language":"ja-Kana","@value":"ダイニカイ チバ イガッカイ ショウレイショウ シシンケイ セキズイエン ト タハツセイ コウカショウ ノ メンエキ ビョウタイ ノ ソウイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1050575520347494400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002217771228160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Relationship Between NMO-Antibody and Anti–MOG Antibody in Optic Neuritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002218935260416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differential diagnosis of neuromyelitis optica spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002219072390272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004229898617088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Copy number variations in multiple sclerosis and neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004231226330752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232142369408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232300280320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232381044736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004234915304320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Neuromyelitis optica spectrum disorders: still evolving and broadening"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235484954880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cytokines and Chemokines in Neuromyelitis Optica: Pathogenetic and Therapeutic Implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235485576832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin‐4 competing with the neuromyelitis optica autoantibody, NMO‐IgG"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235493056000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Connexin pathology in acute multiple sclerosis,<scp>B</scp>aló's disease and neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235493415808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"<scp>Neuromyelitis optica</scp> spectrum and <scp>myelin oligodendrocyte glycoprotein</scp> antibody‐related disseminated encephalomyelitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235803249408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236342605568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236706539776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjögren’s syndrome patients with central nervous system manifestations"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236706567040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236800998400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"T cell-activation in neuromyelitis optica lesions plays a role in their formation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236951227136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Aquaporin-4 antibody–positive cases beyond current diagnostic criteria for NMO spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004237536633344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004239450312960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005520493668736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Neuropathological features of “non‐motor” symptoms in multiple sclerosis and neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360005520493690368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Perivenous demyelination: Association with anti‐myelin oligodendrocyte glycoprotein antibody"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142459832320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168785794048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017280642182656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immuno-pathogenesis of neuromyelitis optica and emerging therapies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017289333624064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390751792640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ"}]},{"@id":"https://cir.nii.ac.jp/crid/1360023717932914176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevalence of, and Disability Due to, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Japan by the Fifth Nationwide Survey"}]},{"@id":"https://cir.nii.ac.jp/crid/1360023720969768064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Interleukin-6 Signaling Blockade Induces Regulatory Plasmablasts in Neuromyelitis Optica Spectrum Disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430195316224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690320735616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Detection of mumps virus RNA in cerebrospinal fluid of patients with neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691060133760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691428408832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693894736128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"“Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693894780160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693959497856","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693987062528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693987078656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285704875165184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Proteomic pattern analysis discriminates among multiple sclerosis–related disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706202786816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Aquaporin-4 astrocytopathy in Baló’s disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707275126016","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709458338944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Novel Monoclonal Antibody Against the C-Terminal Region of Aquaporin-4"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710469778304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gray matter involvement in multiple sclerosis and neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710469940352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical characteristics of autoimmune optic neuritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710720312448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reappraisal of Aquaporin‐4 Astrocytopathy in Asian Neuromyelitis Optica and Multiple Sclerosis Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711069818240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711926867200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Devic disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711927343872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Area postrema syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711927780096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pain in neuromyelitis optica and its effect on quality of life"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285712564712448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617436514816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Risk factors of attacks in neuromyelitis optica spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617437252608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617472832640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Genetic factors for susceptibility to and manifestations of neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617474506112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757423299328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Association of cerebrospinal inflammatory profile with radiological features in newly diagnosed treatment-naïve patients with multiple sclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865735700864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunological regulation and the role of autophagy in preeclampsia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565164363828992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cognitive impairment and cortical degeneration in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165260093696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165982548608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168871414144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169025803904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fulminant demyelinating encephalomyelitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169025915008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Challenges and opportunities in designing clinical trials for neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169025925888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169025951616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pregnancy outcomes in aquaporin-4–positive neuromyelitis optica spectrum disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169026491392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169377334656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169383011200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Connexin 43 Astrocytopathy Linked to Rapidly Progressive Multiple Sclerosis and Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565169407625984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567179851986432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cerebrospinal fluid aquaporin‐4 antibody levels in neuromyelitis optica attacks"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567179852055040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological features in anterior visual pathway in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181956156032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The binding property of a monoclonal antibody against the extracellular domains of aquaporin-4 directs aquaporin-4 toward endocytosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181976546048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181977604992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeting of aquaporin 4 into lipid rafts and its biological significance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182251970048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182253692416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183404891904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Towards more-accurate diagnosis in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183436747008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhibition of RGMa alleviates symptoms in a rat model of neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184055354112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical Characteristics of Anti-aquaporin 4 Antibody Positive Optic Neuritis in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185446484480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy of methylprednisolone pulse therapy for acute relapse in <scp>J</scp>apanese patients with multiple sclerosis and neuromyelitis optica: A multicenter retrospective analysis – 1. Whole group analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185446536448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Distinct features of immunoglobulin G2 aquaporin‐4 antibody carriers with neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185708883584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185756659584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Early disruption of glial communication via connexin gap junction in multiple sclerosis,<scp>B</scp>aló's disease and neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567187463475200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Genetic and Infectious Profiles of Japanese Multiple Sclerosis Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189152942336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical Profile of Anti-Myelin Oligodendrocyte Glycoprotein Antibody Seropositive Cases of Optic Neuritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189446607232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Neuroimmunological Implications of AQP4 in Astrocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092412878592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092457832192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Early Treatment Initiation With Oral Prednisolone for Relapse Prevention Alleviates Depression and Fatigue in Aquaporin-4–Positive Neuromyelitis optica Spectrum Disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118743301120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Very late onset neuromyelitis optica spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118781847040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118833210624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Radiological and Laboratory Features of Multiple Sclerosis Patients With Immunosuppressive Therapy: A Multicenter Retrospective Study in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576284229534848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: Evaluation by advanced diffusion imaging"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232416683136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Autoimmunity to ion channels in neurological diseases–Autoimmunity to aquaporin water channels"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340724030976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588379362893312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Inhibition of repulsive guidance molecule-a ameliorates compromised blood–spinal cord barrier integrity associated with neuromyelitis optica in rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846642459606400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643074893696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643381906816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846644002617472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"MRI characteristics of neuromyelitis optica spectrum disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846644002794112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846644003171968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Myasthenia gravis and neuromyelitis optica spectrum disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846645586064640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848655050914176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fatty acid‐binding protein 7 regulates function of caveolae in astrocytes through expression of caveolin‐1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656343877376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical Relevance of Serum Aquaporin-4 Antibody Levels in Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656924561024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657228554752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Establishment of monoclonal antibodies against the extracellular domain that block binding of NMO-IgG to AQP4"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657235034880","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Neuromyelitis optica: Concept, immunology and treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658381591040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pain in neuromyelitis optica—prevalence, pathogenesis and therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659480154496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660415070592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"New Insights, Promises and Challenges"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660415076608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical Spectrum and Treatment of Neuromyelitis Optica Spectrum Disorders: Evolution and Current Status"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660423138560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Reactive astrocytes express the potassium channel <scp>K</scp>ir4.1 in active multiple sclerosis lesions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660423154048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Role of interleukin‐6 in the pathogenesis of neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848660423171328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cortical degeneration in neuromyelitis optica: Potential pathogenesis of cognitive impairment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661636606848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661636663680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pathological study of subacute autoimmune encephalopathy with anti-AQP4 antibodies in a pregnant woman"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661636826624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661881382784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"AQP4 antibody serostatus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849939371028352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567363231872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567389488256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Optic neuritis after ocular trauma in anti‐aquaporin‐4 antibody‐positive neuromyelitis optica spectrum disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567390909184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSD"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861288121780864","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Update on glial antibody-mediated optic neuritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865120765771392","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865815672275968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dynamic changes in patient admission and their disabilities in multiple sclerosis and neuromyelitis optica: A Japanese nationwide administrative data study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131420400535424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361131421018672128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204651627264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment of Neuromyelitis Optica"},{"@language":"ja","@value":"視神経脊髄炎（NMO）の治療をめぐって"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204680070656","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Therapeutic apheresis for neuromyelitis optica and neuromyelitis optica spectrum disorders"},{"@language":"ja","@value":"Neuromyelitis opticaおよびNeuromyelitis optica spectrum disordersに対するアフェレシス療法の有効性"},{"@value":"症例報告 Neuromyelitis opticaおよびNeuromyelitis optica spectrum disordersに対するアフェレシス療法の有効性"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク Neuromyelitis optica オヨビ Neuromyelitis optica spectrum disorders ニ タイスル アフェレシス リョウホウ ノ ユウコウセイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204871535872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Acute Combined Central and Peripheral Demyelination Showing Anti-Aquaporin 4 Antibody Positivity"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204872483840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Recurrent Spinal Cord Attacks in a Patient with a Limited Form of Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204876765824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Neuromyelitis Optica Spectrum Disorder with Recurrent Intracranial Hemorrhage"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205028436864","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Future Perspectives of Neuroimmunological Disease Research"},{"@value":"神経免疫疾患研究の将来展望"},{"@language":"ja-Kana","@value":"シンケイ メンエキ シッカン ケンキュウ ノ ショウライ テンボウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205035106176","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Aberrant cross talk between immune cells and neural cells in demyelinating disorders"},{"@language":"ja","@value":"シンポジウム０３‐２　脱髄性疾患におけるグリア間およびグリア・ニューロン間相互作用の破綻　ＭＳ／ＮＭＯのモデルからみた脱髄性疾患における免疫細胞・グリア・ニューロン間相互作用の異常"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205035937280","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"原発性シェーグレン症候群（SjS）に視神経炎と脳脊髄炎を合併し，抗アクアポリン4抗体が陽性であった25歳女性例"},{"@language":"en","@value":"A 25-year-old woman with primary Sjögren syndrome who developed optic neuritis and encephalomyelitis associated with an anti-aquaporin 4 antibody"},{"@value":"症例報告 原発性シェーグレン症候群(SjS)に視神経炎と脳脊髄炎を合併し,抗アクアポリン4抗体が陽性であった25歳女性例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク ゲンパツセイ シェーグレン ショウコウグン SjS ニ シシンケイエン ト ノウセキズイエン オ ガッペイ シ コウアクアポリン 4 コウタイ ガ ヨウセイ デ アッタ 25サイ ジョセイレイ"},{"@value":"A 25-year-old woman with primary Sj&ouml;gren syndrome who developed optic neuritis and encephalomyelitis associated with an anti-aquaporin 4 antibody"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205035940224","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"日本人多発性硬化症の臨床研究における最近の進歩"},{"@language":"en","@value":"Recent advances of multiple sclerosis research in Japan"},{"@language":"ja-Kana","@value":"ニホンジン タハツセイ コウカショウ ノ リンショウ ケンキュウ ニ オケル サイキン ノ シンポ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205036260352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"What I have learned and accomplished through research on multiple sclerosis (MS)"},{"@language":"ja","@value":"会長講演　多発性硬化症の研究を通して学んできたこと"},{"@language":"ja-Kana","@value":"カイチョウ コウエン タハツセイ コウカショウ ノ ケンキュウ オ トオシテ マナンデ キタ コト"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205036499968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of anti-aquaporin 4 antibody-positive Sjoegren syndrome associated with a relapsed myelitis in pregnancy"},{"@language":"ja","@value":"抗ａｑｕａｐｏｒｉｎ　４抗体が陽性で妊娠中に脊髄炎が再発したシェーグレン症候群の１例"},{"@language":"ja-Kana","@value":"コウaquaporin4 コウタイ ガ ヨウセイ デ ニンシン チュウ ニ セキズイエン ガ サイハツ シタ シェーグレン ショウコウグン ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205037250560","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Humoral and cellular immune responses in neuromyelitis optica"},{"@value":"シンポジウム05―5　中枢神経の免疫疾患とグリア　Humoral and cellular immune responses in neuromyelitis optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205037489280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of myelitis with anti-aquaporin 4 antibody concomitant with immune thrombocytopenic purpura"},{"@language":"ja","@value":"特発性血小板減少性紫斑病を合併した抗アクアポリン4抗体陽性脊髄炎の1例"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205194627584","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Case of Anti-aquaporin-4 and Anti-glutamate Receptor Antibodies Positive Myelitis Presented with Modest Clinical Signs"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205517982592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"小児期発症の抗アクアポリン4抗体陽性症例の臨床像"},{"@language":"en","@value":"Clinical Features of Japanese Pediatric Patients with Anti-Aquaporin 4 Antibody"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206443803776","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"3. Guideline for Nervous System Disease and Its Validation - Emphasis on Immune and Nervous System Diseases"},{"@language":"ja","@value":"3．神経系疾患のガイドラインとその検証：免疫性神経疾患を中心に"},{"@value":"神経系疾患のガイドラインとその検証--免疫性神経疾患を中心に"},{"@language":"ja-Kana","@value":"シンケイケイ シッカン ノ ガイドライン ト ソノ ケンショウ メンエキセイ シンケイ シッカン オ チュウシン ニ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206445684992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Case of Neuromyelitis Optica Complicated by Posterior Reversible Encephalopathy Syndrome and a Papillary Thyroid Cancer."},{"@language":"ja","@value":"経過中にposterior reversible encephalopathy syndrome（PRES）と甲状腺癌を合併した視神経脊髄炎の47歳女性例"},{"@value":"今月の症例 経過中にposterior reversible encephalopathy syndrome(PRES)と甲状腺癌を合併した視神経脊髄炎の47歳女性例"},{"@language":"ja-Kana","@value":"コンゲツ ノ ショウレイ ケイカ チュウ ニ posterior reversible encephalopathy syndrome PRES ト コウジョウセンガン オ ガッペイ シタ シシンケイ セキズイエン ノ 47サイ ジョセイレイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206445788928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"11. Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO)"},{"@language":"ja","@value":"11．多発性硬化症（MS）と視神経脊髄炎（NMO）"},{"@value":"教育講演 多発性硬化症(MS)と視神経脊髄炎(NMO)"},{"@language":"ja-Kana","@value":"キョウイク コウエン タハツセイ コウカショウ(MS)ト シシンケイ セキズイエン(NMO)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206448894208","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"最新の多発性硬化症治療"},{"@language":"en","@value":"The Latest Treatment for Multiple Sclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288042316672","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"ステロイド抵抗性の抗アクアポリン4抗体陽性視神経炎に対し二重膜濾過血漿交換療法が奏功した1例"},{"@language":"en","@value":"Successful treatment of steroid-resistant anti-aquaporin 4 antibody-positive optic neuritis with double-filtration plasmapheresis: a case report"},{"@value":"症例報告 ステロイド抵抗性の抗アクアポリン4抗体陽性視神経炎に対し二重膜濾過血漿交換療法が奏功した1例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク ステロイド テイコウセイ ノ コウアクアポリン 4 コウタイ ヨウセイ シシンケイエン ニ タイシ ニジュウマク ロカ ケッショウ コウカン リョウホウ ガ ソウコウ シタ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390007216692162176","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Glucose-Regulated Protein 78 Autoantibody Associates with Blood-brain Barrier Disruption in Neuromyelitis Optica"},{"@language":"ja","@value":"視神経脊髄炎患者から血液脳関門破綻に関与するGRP78抗体の同定"},{"@language":"ja-Kana","@value":"シシンケイ セキズイエン カンジャ カラ ケツエキ ノウ カンモン ハタン ニ カンヨ スル GRP78 コウタイ ノ ドウテイ ミニ レビュー : コニシショウ ジュショウシャ"},{"@value":"小西賞受賞者 視神経脊髄炎患者から血液脳関門破綻に関与するGRP78抗体の同定"},{"@language":"ja-Kana","@value":"コニシショウ ジュショウシャ シシンケイ セキズイエン カンジャ カラ ケツエキ ノウ カンモン ハタン ニ カンヨ スル GRP78 コウタイ ノ ドウテイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390010457669441792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"An Autopsy Confirmed Neuromyelitis Optica Spectrum Disorder with Extensive Brain White Matter Lesion and Optic Neuritis but Intact Spinal Cord, Clinically Mimicking a Secondary Progressive Multiple Sclerosis-like Course"}]},{"@id":"https://cir.nii.ac.jp/crid/1390013706734638720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of Paraneoplastic Neuromyelitis Optica after Lung Resection in a Patient with Squamous Cell Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679216071424","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Establishment of a New Sensitive Assay for Anti-Human Aquaporin-4 Antibody in Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679216558336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Loss of Aquaporin-4 in Active Perivascular Lesions in Neuromyelitis Optica: A Case Report"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679217570944","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Prominent Elevation of Glial Fibrillary Acidic Protein in the Cerebrospinal Fluid during Relapse in Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679654808320","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"吃逆・食欲不振に続き, 両側視神経炎を呈したNMO spectrum disorderに対して血漿交換が著効した1例"},{"@language":"en","@value":"Successful treatment of neuromyelitis optica spectrum disorder combined with bilateral optic neuritis via plasma exchange"},{"@value":"症例報告 吃逆・食欲不振に続き,両側視神経炎を呈したNMO spectrum disorderに対して血漿交換が著効した1例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク シャックリ ・ ショクヨク フシン ニ ツズキ,リョウガワ シシンケイエン オ テイシタ NMO spectrum disorder ニ タイシテ ケッショウ コウカン ガ チョコウシタ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679657570688","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Immunoabsorption plasma pheresis (IAPP) therapy for neuromyelitis optica (NMO) spectrum disorders in two cases"},{"@language":"ja","@value":"免疫吸着療法（ＩＡＰＰ）により軽快しえた視神経脊髄炎（ＮＭＯ）関連疾患の２例"},{"@value":"症例報告 免疫吸着療法(IAPP)により軽快しえた視神経脊髄炎(NMO)関連疾患の2例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク メンエキ キュウチャク リョウホウ IAPP ニ ヨリ ケイカイ シエタ シシンケイ セキズイエン NMO カンレン シッカン ノ 2レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679847079936","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"An Autopsy Case of Sjoegren's Syndrome with Acute Encephalomyelopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679850372096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Recurrent Brainstem Lesions Mimicking Infarctions in an Elderly Patient with Neuromyelitis Optica Spectrum Disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680011136000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antibody-related neuroimmunological disorders: Update on the diagnosis and treatment"},{"@language":"ja","@value":"Ｈｏｔ　Ｔｏｐｉｃｓ　３　自己抗体と神経疾患‐病態に関わる抗体の最近の動向‐"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680011352448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of anti-AQP4 antibody-positive recurrent myelitis overlapped with autoimmune disorders including incomplete CREST syndrome revealed multiple discontinuous cord lesions"},{"@language":"ja","@value":"不全型ＣＲＥＳＴ症候群に複数の自己免疫疾患を合併し，非連続性多発脊髄病変を呈した抗ＡＱＰ４抗体陽性再発性脊髄炎の１例"},{"@language":"ja-Kana","@value":"フゼンガタ CREST ショウコウグン ニ フクスウ ノ ジコ メンエキ シッカン オ ガッペイ シ ヒレンゾクセイ タハツ セキズイ ビョウヘン オ テイシタ コウAQP4 コウタイ ヨウセイ サイハツセイ セキズイエン ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680011395584","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"To search for the pathogenesis of multiple sclerosis from the bedside"},{"@language":"ja","@value":"シンポジウム４‐１　多発性硬化症の病態と治療：臨床と基礎の最前線　病態の解明をめざして「臨床からの考察」"},{"@value":"病態の解明をめざして「臨床からの考察」"},{"@language":"ja-Kana","@value":"ビョウタイ ノ カイメイ オ メザシテ リンショウ カラノ コウサツ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680011407744","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Progress in unravelling the etiology of multiple sclerosis?"},{"@language":"ja","@value":"教育講演２　多発性硬化症の病態はどこまでわかったか？"},{"@value":"教育講演 多発性硬化症の病態はどこまでわかったか?"},{"@language":"ja-Kana","@value":"キョウイク コウエン タハツセイ コウカショウ ノ ビョウタイ ワ ドコマデ ワカッタカ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680011816448","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Astrocytopathy in neuromyelitis optica, multiple sclerosis and Balo's disease"},{"@language":"ja","@value":"シンポジウム０３‐３　脱髄性疾患におけるグリア間およびグリア・ニューロン間相互作用の破綻　視神経脊髄炎，多発性硬化症，Ｂａｌｏ病におけるアストロサイト障害の特徴"},{"@value":"Astrocytopathy in neuromyelitis optica, multiple sclerosis and Baló's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680012039552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Neuromyelitis optica in a patient with Sjoegren syndrome with distal renal tubular acidosis: A case report"},{"@language":"ja","@value":"遠位尿細管性アシドーシスをともなうシェーグレン症候群に発症した視神経脊髄炎の１例"},{"@language":"ja-Kana","@value":"エンイ ニョウ サイカンセイ アシドーシス オ トモナウ シェーグレン ショウコウグン ニ ハッショウ シタ シシンケイ セキズイエン ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680012056064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"私のKeep Pioneering：神経科学と免疫科学の統合による神経難病のパラダイムシフトをめざして"},{"@language":"en","@value":"My way to “Keep Pioneering”: Integrated neuroscience and immunology research produces a paradigm shift for intractable neurological disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680208793088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"脊髄外科医に必要なNMOの知識"},{"@language":"en","@value":"Knowledge of Neuromyelitis Optica for Spinal Surgeon"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680494686336","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"血漿交換が有効であったneuromyelitis opticaの1例"},{"@language":"en","@value":"Successful Plasma Exchange Treatment for a Case with Neuromyelitis Optica"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680743400448","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Inpatient Multidisciplinary Rehabilitation Intervention Outcomes for          Neuromyelitis Optica Spectrum Disorder: A Retrospective Observational          Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681420584832","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"5. Autoimmunity and Allergy of Central Nerve"},{"@language":"ja","@value":"5．中枢神経の自己免疫とアレルギー"},{"@value":"中枢神経の自己免疫とアレルギー"},{"@language":"ja-Kana","@value":"チュウスウ シンケイ ノ ジコ メンエキ ト アレルギー"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681420917760","@type":"Article","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A 32-year-old Man with Neuromyelitis Optica Presenting Peculiar Itching."},{"@language":"ja","@value":"特異な掻痒を呈したneuromyelitis opticaの32歳男性例"},{"@value":"今月の症例 特異な掻痒を呈したneuromyelitis opticaの32歳男性例"},{"@language":"ja-Kana","@value":"コンゲツ ノ ショウレイ トクイ ナ ソウヨウ オ テイシタ neuromyelitis optica ノ 32サイ ダンセイレイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390288248211605760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Case of Neuromyelitis Optica Spectrum Disorder Who Relapsed Under Oral Corticosteroid Treatment with Multiple Cerebrospinal Lesions and Severe Neurological Deficits"},{"@language":"ja","@value":"ステロイド内服下に多発脳脊髄病変で再発し，重篤な神経障害を残したNeuromyelitis Optica Spectrum Disordersの1例"},{"@language":"ja-Kana","@value":"ステロイド ナイフク カ ニ タハツ ノウ セキズイ ビョウヘン デ サイハツ シ,ジュウトク ナ シンケイ ショウガイ オ ノコシタ Neuromyelitis Optica Spectrum Disorders ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390292240175888512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Seroconversion of anti-aquaporin-4 antibody in a patient with neuromyelitis optica spectrum disorder: a case report"},{"@language":"ja","@value":"発症時抗アクアポリン4抗体陰性であり，のちに陽性に転じた視神経脊髄炎スペクトラム障害の1例"}]},{"@id":"https://cir.nii.ac.jp/crid/1390292936928099328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"History and prospects of multiple sclerosis treatment"},{"@language":"ja","@value":"多発性硬化症の治療史と将来展望"}]},{"@id":"https://cir.nii.ac.jp/crid/1390305721534523776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"脊柱管外の神経根腫大および末梢神経脱髄所見を伴ったAQP4抗体陽性視神経脊髄炎スペクトラム障害の1例"},{"@language":"en","@value":"AQP4 positive neuromyelitis optica spectrum disorder: an atypical pathology with nerve root enlargement and peripheral nervous system damage in demyelination"}]},{"@id":"https://cir.nii.ac.jp/crid/1390307269696429696","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"神経免疫疾患の最近の動向"},{"@language":"en","@value":"Recent Advances in Neuroimmunological Disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1390573242730144640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of neuromyelitis optica spectrum disorders associated with primary biliary cholangitis: a twelve year follow-up study"},{"@language":"ja","@value":"原発性胆汁性胆管炎を合併した視神経脊髄炎スペクトラム障害の1例：12年間の経過観察"}]},{"@id":"https://cir.nii.ac.jp/crid/1390574500939679616","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"II. Neuromyelitis Optica Spectrum Disorder"},{"@language":"ja","@value":"II．視神経脊髄炎スペクトラム障害"}]},{"@id":"https://cir.nii.ac.jp/crid/1390575108419037440","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Multiple sclerosis"},{"@language":"ja","@value":"3. 多発性硬化症"}]},{"@id":"https://cir.nii.ac.jp/crid/1390577763027447168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Paraneoplastic Neuromyelitis Optica Spectrum Disorder Related to Glucose-regulated Protein 78 (GRP78) Autoantibodies in a Patient with Lynch Syndrome-associated Colorectal Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845713069069184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of neuromyelitis optica spectrum disorders, with slowly progressive bulbar palsy, mimicking a motor neuron disease"},{"@language":"ja","@value":"緩徐に進行する球麻痺症状を呈し，運動ニューロン疾患が疑われた視神経脊髄炎関連疾患の1例"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845713080254464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Co-existing of Neuromyelitis Optica and Fulminant Type 1 Diabetes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390854717938686720","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Detection of anti-aquaporin 4 antibody"},{"@language":"ja","@value":"抗Aquaporin-4 抗体の蛍光顕微鏡による検出について"}]},{"@id":"https://cir.nii.ac.jp/crid/1390870297797552128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Progress in the Treatment of Neuromyelitis Optica Spectrum Disorder: From Pathogenic Insights to Biologics"}]},{"@id":"https://cir.nii.ac.jp/crid/1520010380523625728","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"臨床と疫学"},{"@language":"ja-Kana","@value":"リンショウ ト エキガク"}]},{"@id":"https://cir.nii.ac.jp/crid/1520290884330791424","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"多発性硬化症における抗アクアポリン4抗体の診断的意義"},{"@language":"ja-Kana","@value":"タハツセイ コウカショウ ニ オケル コウアクアポリン 4 コウタイ ノ シンダンテキ イギ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520572357078625920","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"第115回 日本眼科学会総会 評議員会指名講演 緑内障研究の進歩 緑内障性視神経症への挑戦 : 新しい病態論の提唱と他覚的機能解析方法の改良"},{"@language":"ja-Kana","@value":"ダイ115カイ ニホン ガンカ ガッカイ ソウカイ ヒョウギインカイ シメイ コウエン リョクナイショウ ケンキュウ ノ シンポ リョクナイショウセイ シシンケイショウ エ ノ チョウセン : アタラシイ ビョウタイロン ノ テイショウ ト タ カクテキ キノウ カイセキ ホウホウ ノ カイリョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520572358006845952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"視神経脊髄型多発性硬化症--臨床検査のトピックス"},{"@language":"ja-Kana","@value":"シシンケイ セキズイガタ タハツセイ コウカショウ リンショウ ケンサ ノ トピックス"}]},{"@id":"https://cir.nii.ac.jp/crid/1520572358094518400","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"教育講演 視神経脊髄型多発性硬化症を考える"},{"@language":"ja-Kana","@value":"キョウイク コウエン シシンケイ セキズイガタ タハツセイ コウカショウ オ カンガエル"}]},{"@id":"https://cir.nii.ac.jp/crid/1520572358752577024","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"視神経脊髄炎(NMO)の疾患概念,病態と治療"},{"@language":"ja-Kana","@value":"シシンケイ セキズイエン NMO ノ シッカン ガイネン ビョウタイ ト チリョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1520854806141665664","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"血漿交換療法により視力が改善した視神経脊髄炎の一例"},{"@language":"ja-Kana","@value":"ケッショウ コウカン リョウホウ ニ ヨリ シリョク ガ カイゼン シタ シシンケイ セキズイエン ノ イチレイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1521136279878786176","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"視神経炎アップデート\"抗アクアポリン4抗体陽性視神経炎\""},{"@language":"ja-Kana","@value":"シシンケイエン アップデート コウアクアポリン 4 コウタイ ヨウセイ シシンケイエン"}]},{"@id":"https://cir.nii.ac.jp/crid/1521136280420607616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"視神経脊髄炎の病理学的特徴"},{"@language":"ja-Kana","@value":"シシンケイ セキズイエン ノ ビョウリガクテキ トクチョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1521417755097288192","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"視神経脊髄炎の治療法--最近のエビデンスを元に"},{"@language":"ja-Kana","@value":"シシンケイ セキズイエン ノ チリョウホウ サイキン ノ エビデンス オ モト ニ"}]},{"@id":"https://cir.nii.ac.jp/crid/1522543654685071872","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"多発性硬化症・視神経脊髄炎の免疫学的背景"},{"@language":"ja-Kana","@value":"タハツセイ コウカショウ シシンケイ セキズイエン ノ メンエキガクテキ ハイケイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1522825130543277184","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"実験的自己免疫性視神経炎"},{"@language":"ja-Kana","@value":"ジッケンテキ ジコ メンエキセイ シシンケイエン"}]},{"@id":"https://cir.nii.ac.jp/crid/1522825130696255872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"視神経炎に抗AQP4抗体を検査すべきか?治療法は変わるか?"},{"@language":"ja-Kana","@value":"シシンケイエン ニ コウAQP4 コウタイ オ ケンサ スベキ カ?チリョウホウ ワ カワル カ?"}]},{"@id":"https://cir.nii.ac.jp/crid/1522825131037914368","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current understanding of the epidemiologic and clinical characteristics of optic neuritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1523106604888889600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CLINICAL INVESTIGATION : Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1523106606058776960","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Visual outcome of aquaporin-4 antibody-positive optic neuritis with maintenance therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1524232504882934528","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"CLINICAL INVESTIGATION : Visual function and inner retinal structure correlations in aquaporin-4 antibody-positive optic neuritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1571135650746309760","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A patient with neuromyelitis optica with positive anti-Ro (SS-A) antibody presenting with intractable hiccup and nausea"}]},{"@id":"https://cir.nii.ac.jp/crid/1571417126175879680","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"視神経脊髄炎とアクアポリン4抗体 : アストログリア病との出会い"}]},{"@id":"https://cir.nii.ac.jp/crid/1573668925944299136","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950400596994176","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Spinal cord biopsy findings of anti-aquaporin-4 antibody-negative recurrent longitudinal myelitis in a patient with sicca symptoms and hepatitis C viral infection"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0140-6736(04)17551-x"},{"@type":"CIA","@value":"30006113053"},{"@type":"OPENAIRE","@value":"doi_dedup___::d8d79498f214ca135543c9ad2ff2dd4d"},{"@type":"CROSSREF","@value":"10.1177/1756285617709723_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/ana.24511_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s00401-015-1501-5_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1097/wco.0000000000000694_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/bpa.12097_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/bph.13340_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12062_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12491_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/neup.12216_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1155/2012/862169_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1177/1352458511431727_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1177/1352458512454772_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1186/2051-5960-1-85_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0000000000002208_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0083036_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1620/tjem.210.307_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.51.7590_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3389/fneur.2018.00888_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/s1474-4422(17)30470-2_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12533_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12569_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jns.2010.01.009_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.exer.2013.12.010_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.50.4430_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.51.6351_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.51.894_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.50.27_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.48.849_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.50.873_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2177/jsci.35.129_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2463/mrms.7.55_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.braindev.2014.04.013_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.49.576_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2342/ymj.68.23_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.msard.2021.102750_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-001211_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-04074-1_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/naika.110.1568_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/ene.14901_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0b013e318229e694_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s00281-022-00941-9_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0b013e318296ea08_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s00401-024-02725-x_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3390/biomedicines13030718_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s10072-011-0564-x_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1177/1352458513495581_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1177/1352458514567216_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1186/s40478-015-0259-2_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1186/s40478-016-0355-y_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/ana.22633_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s00401-010-0733-7_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s10165-011-0572-y_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s10384-018-0602-9_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12077_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12354_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/j.1750-3639.2011.00475.x_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1136/jnnp-2013-305907_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0000000000001729_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0000000000006392_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0151244_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2013.03.003_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.brainres.2014.08.014_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.bbrep.2016.05.017_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2012.09.002_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/naika.98.496_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/naika.102.2426_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/naika.99.1650_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.49.699_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.4009/jsdt.44.969_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5363/tits.16.7_66_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2017.07.006_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1089/mab.2013.0007_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2490/prm.20160007_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1186/2051-5960-1-5_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s10384-018-0607-4_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s10384-021-00858-0_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2020.577236_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1186/s40478-020-00920-x_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/acn3.51147_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3389/fneur.2020.00501_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3757/jser.81.173_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.12936/tenrikiyo.12-004_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.9783-22_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0000000000001520_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3389/fneur.2022.1012857_references_DOI_HML80gyBP9SFxREzEofXWiuzc4X"},{"@type":"CROSSREF","@value":"10.1080/25785826.2024.2304364_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/aji.13835_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2490/jjrmc.62.1169_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/ana.23721_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s00401-013-1116-7_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1177/1352458512443917_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0061835_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0072919_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0122000_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/ana.24208_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/ana.24608_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1038/nrneurol.2014.216_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1038/s41598-017-18362-2_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1080/01658107.2018.1520905_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12071_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12179_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/j.1759-1961.2012.00030.x_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/neup.12211_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0000000000004611_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0048592_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1620/tjem.215.55_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3109/01658107.2015.1072726_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3390/ijms17081306_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1620/tjem.209.269_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.msard.2018.08.023_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jns.2010.05.014_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.47.0207_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/naika.98.571_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.48.931_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.50.168_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.49.115_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.50.813_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.54.195_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.4009/jsdt.45.413_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.7888/juoeh.43.255_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/naika.105.894_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5761/atcs.cr.21-00144_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s00415-020-10377-6_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3389/fneur.2021.608149_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.4009/jsdt.51.379_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/nxi.0000000000001076_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3389/fneur.2021.749406_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jns.2022.120205_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-001668_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0b013e31825644ff_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0000000000000322_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0b013e3182703ff7_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/ncn3.12653_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/nxi.0000000000200173_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-002077_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2024.578297_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0000000000209992_references_DOI_HML80gyBP9SFxREzEofXWiuzc4X"},{"@type":"CROSSREF","@value":"10.1016/j.xgen.2025.100776_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/nxi.0000000000200266_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.6772-25_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1093/brain/aws109_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/bpa.12099_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1126/scitranslmed.aai9111_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0171880_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3389/fneur.2018.00217_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/glia.22784_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s11064-013-1009-0_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1038/nrneurol.2014.129_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1093/brain/awz054_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/bpa.12086_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/bpa.12087_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12011_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12024_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12041_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1177/1352458509355067_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1177/1352458511422928_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1177/1352458515617248_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/nxi.0000000000000175_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/nxi.0000000000000311_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/acn3.50905_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.cca.2018.05.026_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.msard.2017.07.023_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/naika.99.1913_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.51.898_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.54.939_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2531/spinalsurg.25.114_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.7635-21_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cei.13487_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1002/brb3.2083_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.3389/fneur.2020.00932_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-001626_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-001751_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s10384-022-00932-1_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0b013e3182a6cc23_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1212/wnl.0000000000001367_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s10384-024-01129-4_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.msard.2023.105349_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.ophtha.2019.04.042_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1111/cen3.12578_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1136/jnnp-2019-322286_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.49.549_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.56.7889_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1097/wno.0b013e31823c9b6c_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.4009/jsdt.50.555_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.2353-18_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jns.2013.05.035_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.bbacli.2015.01.003_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1016/j.jocn.2012.12.022_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"},{"@type":"CROSSREF","@value":"10.1007/s10384-021-00840-w_references_DOI_AtQi8f2OHD6oLGPQVeWfDBPnY3W"}]}